Ferric Carboxymaltose Injection – Manufacturer, Exporter & Supplier

What is Ferric Carboxymaltose Injection?
Ferric Carboxymaltose Injection is a parenteral iron preparation used in the treatment of iron deficiency anemia when oral iron therapy is ineffective, not tolerated, or contraindicated. It provides high-dose iron replacement in a single infusion, allowing rapid correction of anemia and replenishment of iron stores. It is commonly used in nephrology, gynecology, oncology, and critical care.
 
Uses of Ferric Carboxymaltose Injection
Treatment of iron deficiency anemia (IDA) in adults
Management of anemia in chronic kidney disease (CKD)
Correction of anemia in pregnant and postpartum women
Supportive care in oncology and chemotherapy-induced anemia
Rapid iron replacement in patients intolerant to oral iron therapy
 
How Does Ferric Carboxymaltose Injection Work?
Ferric Carboxymaltose is a stable iron-carbohydrate complex. After intravenous administration, iron is released in a controlled manner and becomes available for hemoglobin synthesis, myoglobin production, and iron-containing enzymes. This results in faster recovery from anemia compared to oral supplements.
 
FAQs on Ferric Carboxymaltose Injection
Q1: What is Ferric Carboxymaltose Injection used for?
It is used for the treatment of iron deficiency anemia, especially when oral therapy is not suitable.
Q2: How is Ferric Carboxymaltose Injection administered?
It is given by intravenous injection or infusion, usually in a hospital or clinic setting.
Q3: What strengths and packs does Farbe Firma supply?
We supply 50 mg/ml concentration in 10 ml and 20 ml vials, customizable per market requirements.
Q4: Does Farbe Firma provide dossier and export support?
Yes, we provide CTD/ACTD dossiers, COPP, and full regulatory documentation for smooth global registrations.
 
Looking for a reliable Ferric Carboxymaltose Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for premium-quality IV iron therapy injectables, dossier support, and seamless worldwide exports.